FDA Inspects Slovene Pharmaceutical Company

Ljubljana, 15 July - The U.S. Food and Drug Administration (FDA) inspected plants for the production of the amoxyclav antibiotic of Slovene pharmaceutical company Lek between 17 June and 4 July. Lek is very satisfied with the results of the inspection, as the FDA report revealed no discrepancies in the inspected segments of the production.